Detection of endoglin-expressing CTCs in patients enrolled in an adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (TAPPAS) Meeting Abstract
| Authors: | Ravi, V.; Brohl, A. S.; Chawla, S. P.; Attia, S.; Riedel, R. F.; Liebner, D. A.; Thornton, K. A.; Mallick, A. B.; Davis, D. W.; Cervantes, M.; Liu, W.; Zhu, K.; Alvarez, D.; Theuer, C. P.; Robinson, S. I.; Penel, N.; Stacchiotti, S.; Tap, W. D.; Jones, R. L.; Maki, R. G. |
| Abstract Title: | Detection of endoglin-expressing CTCs in patients enrolled in an adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (TAPPAS) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Language: | English |
| ACCESSION: | WOS:000442916007265 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.e23570 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: e23570 -- Source: Wos |
